Last reviewed · How we verify
Depodur
Depodur is a Small molecule drug developed by Goodman, Evan, M.D.. It is currently FDA-approved. Also known as: Traditional, morphine sulfate extended-release liposome injection.
At a glance
| Generic name | Depodur |
|---|---|
| Also known as | Traditional, morphine sulfate extended-release liposome injection |
| Sponsor | Goodman, Evan, M.D. |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Role of Multimodal Analgesia in Decreasing Perioperative Pain in Tibial Plateau Fractures (EARLY_PHASE1)
- Local Multimodal Injection Versus Regional Anesthesia in Controlling Pain for Treating Rotational Ankle Fractures (EARLY_PHASE1)
- Depodur vs Fentanyl Infusion for Post-C/S Analgesia (NA)
- The Effect of Pain Medication in Children With Acute Abdominal Pain and Its Implication Over the Surgeon's Decision (NA)
- Intrathecal Morphine Versus Epidural Extended Release Morphine for Pediatric Patients Undergoing Spinal Fusion (PHASE4)
- Low Dose Extended-release Epidural and Lumbar Plexus Block Compared to Lumbar Plexus Block for Total Hip Resurfacing (PHASE4)
- Extended-release Epidural Morphine for Acute Post-operative Analgesia Following Selective Dorsal Rhizotomy in Children (NA)
- Effects of Epidural Lidocaine on the Pharmacokinetic and Pharmacodynamic Profiles of DepoDur® After Cesarean Delivery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Depodur CI brief — competitive landscape report
- Depodur updates RSS · CI watch RSS
- Goodman, Evan, M.D. portfolio CI
Frequently asked questions about Depodur
What is Depodur?
Depodur is a Small molecule drug developed by Goodman, Evan, M.D..
Who makes Depodur?
Depodur is developed and marketed by Goodman, Evan, M.D. (see full Goodman, Evan, M.D. pipeline at /company/goodman-evan-m-d).
Is Depodur also known as anything else?
Depodur is also known as Traditional, morphine sulfate extended-release liposome injection.
What development phase is Depodur in?
Depodur is FDA-approved (marketed).
Related
- Manufacturer: Goodman, Evan, M.D. — full pipeline
- Therapeutic area: All drugs in Other
- Also known as: Traditional, morphine sulfate extended-release liposome injection
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing